Saccharomyces cerevisiae strains engineered previously to produce proteins with mammalian high mannose structures showed severe growth defects and decreased protein productivity. In strain YAB101, derived from one of these strains by a mutagenesis technique based on the disparity theory of evolution, these undesirable phenotypes were alleviated. Here we describe further engineering of YAB101 with the aim of synthesizing heterologous glycoproteins with Man 5 GlcNAc 2 , an intermediate for the mammalian hybrid and complex type oligosaccharides. About 60% conversion of Man 8 GlcNAc 2 to Man 5 GlcNAc 2 was observed after integration of Aspergillus saitoi -1,2-mannosidase fused to the transmembrane domain of S. cerevisiae Och1. To obtain a higher yield of the target protein, a protease-deficient version of this strain was generated by disruption of PEP4 and PRB1, resulting in YAB101-4. Inactivation of these vacuolar proteases enhanced the secretion of human interferon-by approximately 10-fold.
Mammalian cell culture has emerged as the most reliable technique for the production of therapeutic glycoproteins. It has, however, several drawbacks, including difficulty in genetic modification, long fermentation times, and vulnerability to viral contamination. The use of yeast to produce therapeutic glycoproteins has significant advantages, including the use of simple genetic modification and expression systems and a high rate of cell proliferation. In yeast, however, glycosylation of proteins differs from that in mammalian cells, which can trigger an immune response in humans. To overcome this problem, yeast cells have been engineered to produce heterologous glycoproteins with mammalian N-linked oligosaccharides. [1] [2] [3] [4] Although Pichia pastoris strains have been developed that produce the mammalian complex type oligosaccharide, [5] [6] [7] we chose Saccharomyces cerevisiae for glycoengineering in view of the wealth of information about genes, metabolism, and secretory mechanisms that is available for this organism. Moreover, the genetic tools and biochemical methods developed for S. cerevisiae allow for convenient analysis and elucidation of biochemical the features of the oligosaccharides and glycoproteins. Furthermore, S. cerevisiae is commonly used in a wide range of industrial processes. Hence we believe that glycoengineering in S. cerevisiae is important.
S. cerevisiae strains in which 3 genes (och1Á mnn1Á mnn4Á) responsible for the biosynthesis of the outer mannan chain were disrupted 8, 9) produced glycoproteins with a mammalian type high mannose structure instead of the mannan type of S. cerevisiae, Man 8 GlcNAc 2 (also referred to as M8 in conjunction with a strain name). By further trimming of the mannose residues of Man 8 GlcNAc 2 with -1,2-mannosidase, Man 5 GlcNAc 2 (abbreviated M5) as an intermediate for the mammalian hybrid and complex type oligosaccharide was synthesized. Since this trimming is the first step in the formation of hybrid and complex type oligosaccarides, increasing its efficiency is critical. Within this strain, however, the conversion of Man 8 GlcNAc 2 was partial, so that overall 10% of the cell-wall mannoprotein contained Man 5 GlcNAc 2 . 8) In addition, the strain was temperature-sensitive and had a growth defect at 30 C, which resulted in a low yield of heterologously produced protein. This decrease in protein productivity forms an obstacle to the engineering of an efficient glycoprotein production system using yeast. Therefore, the development of a S. cerevisiae strain that efficiently produces a protein with Man 5 GlcNAc 2 oligosaccharide is highly desirable.
As reported previously, another och1Á mnn1Á mnn4Á triple disruptant, strain TIY20 (M8), also had a growth defect, was temperature-sensitive, and gave a poor yield of heterologously produced protein. 10) To overcome these deleterious phenotypes, TIY20 (M8) was changed by a mutagenesis technique based on the disparity theory of evolution. 10) This technique employs an error-prone DNA polymerase that lacks the normal proof-reading function and thus allows the introduction of numerous non-lethal mutations into the genome. 11, 12) The resulting mutant strain, YAB101 (M8 Mut, ''Mut'' indicating use of a mutagenesis technique based on the disparity theory of evolution) did not have the growth defect or temperature-sensitive phenotype of the parental TIY20 strain (M8). The efficiency with which a heterologous protein was produced in YAB101 (M8 Mut) also improved in comparison to TIY20 (M8). 10) These properties make YAB101 (M8 Mut) a suitable starting strain for the synthesis of heterologous glycoproteins with mammalian N-linked oligosaccharides.
During heterologous protein production in S. cerevisiae, the target products are often degraded by proteases. Major intracellular proteolytic activities are attributed to vacuolar proteases, proteinases A and B, encoded by the PEP4 and PRB1 genes respectively. 13) Disruption of both genes creates a strain that can be considered protease deficient, providing a higher yield of heterologously produced proteins. 14, 15) In this study, we isolated a useful strain able efficiently to produce proteins glycosylated with Man 5 GlcNAc 2 oligosaccharides by modification of YAB101 (M8 Mut). To trim Man 8 GlcNAc 2 synthesized in YAB101 (M8 Mut) to Man 5 GlcNAc 2 , -1,2-mannosidase encoded by the msdS gene of Aspergillus saitoi was fused to the transmembrane domain of a S. cerevisiae type-II membrane protein and expressed in YAB101 (M8 Mut). Further, to improve protein productivity, we isolated a protease-deficient version of this strain.
Materials and Methods
Yeast strains, media, and genetic methods. The strains used in this study are listed in Table 1 . YPAD and SD media 16) were used to culture yeast cells and to select yeast transformants respectively. Transformation of S. cerevisiae was done by the lithium-acetate method.
17)
Integration of an msdS-expression cassette. The oligonucleotides used in this study are listed in Table 2 . To construct strains TIY20-1 (M5) and YAB101-1 (M5 Mut) by integration of an OCH1TMD-msdS fusion gene, a DNA-fragment coding for aa 37 to 513 of A. saitoi msdS, lacking the signal peptide, was synthesized according to the codon usage of S. cerevisiae and fused to the transmembrane domain (TMD) of S. cerevisiae OCH1 (aa 1 to 60) (Fig. 1A) . This OCH1TMD-msdS fusion gene was inserted into the EcoRI and SalI sites of YEp352GAP-II, yielding plasmid YEp352GAP-II (OCH1TMD-msdS). 18) From this plasmid, the fusion gene, including 
the GAPDH-promoter and terminator, was amplified with Expand High Fidelity Enzyme (Roche, Basel, Switzerland) and primers GAPFNotI and GAPR-KpnI, which created NotI and KpnI restriction sites flanking the expression cassette. The PCR product was TA-cloned into pCR2.1TOPO (Life Technologies, Carlsbad, CA), and from the resulting subclone, the OCH1TMD-msdS expression cassette was cloned as a NotI-KpnI fragment into pRS304. Before yeast transformation, the resulting plasmid was linearized with EcoRV to facilitate integration into the TRP1 locus of TIY20 (M8) or YAB101 (M8 Mut). Correct integration of the OCH1TMD-msdS DNA fragment was confirmed by PCR with primers TRP1-900F and Man1-SalI annealing about 900 bp upstream of the TRP1 promoter and within the msdS gene respectively. Transcription of OCH1TMD-msdS gene was confirmed by RT-PCR by the SuperScript II One-Step RT-PCR System with Platinum Taq DNA Polymerase (Life Technologies) and primers Man1-F and Man1-R.
Gene disruption of PEP4 and PRB1. Strain YAB101-2 (M5 Mut pep4Á) was obtained by displacing PEP4 in YAB101-1 (M5 Mut) with a PEP4-HUH-cassette consisting of Salmonella hisG genes flanking both ends of the URA3 gene (HUH cassette) and extended with regions homologous to the 5 0 and 3 0 UTRs of PEP4 by PCR. For this, the HUH-cassette, cloned as an EcoRI-PvuII fragment from pSP73-HUH 19) between the EcoRI and SmaI sites of pBSIISK (þ) (Agilent Technologies, Inc., Santa Clara, CA), was amplified by PCR in 2 steps, first with primers PEP4-DF and PEP4-DR and then, to extend the overlap with the PEP4 UTRs, with primers PEP4-ELF and PEP4-ELR. The resulting PEP4-HUH PCR product was integrated into YAB101-1 (M5 Mut) by selection of transformants on SD-plates lacking uracil. Correct integration was confirmed by PCR with primers PEP4-F and PEP4-R. To pop out the URA3 marker, 5FOA-selection was done as described by Takamatsu et al.
9) The resulting YAB101-2 (M5 Mut pep4Á) strain was a pep4 disruptant that had lost the URA3 gene, as confirmed by PCR with primers PEP4-F and PEP4-R.
Strains YAB101-3 (M5 Mut prb1Á) and YAB101-4 (M5 Mut pep4Á prb1Á) were constructed in the same manner by disruption of PRB1 in YAB101-1 (M5 Mut) and YAB101-2 (M5 Mut pep4Á) respectively, using PCR-amplified HUH-cassettes with overhangs homologous to the 5 0 and 3 0 UTRs of PRB1. The primers for primary PCR were PRB1-DF and PRB1-DR, and for the second PCR, PRB1-ELF and PRB1-ELR. Replacement of PBR1 by the HUH-cassette was confirmed by PCR with primers PRB1-F and PRB1-R, and subsequent removal of the URA3 marker was confirmed by PCR with primers PRB1-F and PBR1-R.
Construction of human interferon-expression plasmids. To construct plasmid YEp352GAPII-MFhIFN-, the prepro-sequence of the -factor gene was amplified from YEp352GAPII--factor-MUC1 (kindly provided by Dr. Koh Amano of National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan) and cloned as an EcoRI-SacI fragment into YEp352GAP-II 18) to create pGAP2. PCR was done with primers AFsig-NRI and AFsig-CSac. The gene for histidine-tagged human interferon-(hIFN-), containing the enterokinase cleavage site, optimized for S. cerevisiae codon usage, was synthesized by Hokkaido System Science (Sapporo, Japan) and inserted in-frame with the -factor in pGAP2 to yield YEp352GA-PII-MFhIFN-.
Growth analysis. To construct growth curves, YPAD medium was inoculated from fresh pre-cultures, grown overnight in YPAD at 30 C, and incubated at 30 C. To monitor cell growth, the optical density of a culture was determined spectrophotometrically at 600 nm (OD600) (at the indicated time-points in the case of the growth curves). For reliable measurement by OD, cultures were diluted to make the OD600 less than 1. At the indicated time points, OD600 measurements were made to monitor cell growth. For plate-assays, 10-fold serial dilutions of the preculture were spotted onto YPAD plates and then incubated for 2 d at the temperatures indicated.
Analysis of the N-linked oligosaccharides of the mannoproteins. All S. cerevisiae strains were grown in YPAD medium containing 300 mM KCl at 30
C for 72 h, and 60% (w/v) glucose was added every 12 h to maintain a final glucose concentration of 2% (w/v). Extraction of mannoproteins, digestion with glycopeptidase F (Takara Bio, Shiga, Japan), pyridylamination, and structural analysis of the oligosaccharides released were performed as described previously. 8) Purified pyridylaminated (PA) oligosaccharide was analyzed by HPLC (Prominence, Shimadzu, Kyoto, Japan) with a size-fractionation column (TSKgel Amide-80, 3 mm column, 4:6 Â 150 mm, Tosoh, Tokyo) and 2 eluents: 70% acetonitrile and 30% 200 mM triethylamine acetate (eluent A); and 30% acetonitrile and 70% 200 mM triethylamine acetate (eluent B). The column was equilibrated with eluent A at a flow rate of 1 mL/min. After injection of the sample, the concentration of eluent B was increased from 0% to 50% over 50 min. PA-oligosaccharides were detected by measuring the fluorescence (excitation wavelength, 310 nm; emission wavelength 380 nm).
Cytokine ELISA. Interferon-levels in the culture supernatant were measured with a Human IFN-ELISA kit (PBL Interferon Source, Piscataway, NJ). Yeast cells carrying YEp352GAPII-MFhIFNwere grown in 3 mL of YPAD containing 0.3 M sorbitol for 2-3 d at 30
C with aeration. The starting OD600 was 0.1, and the cells grew to OD600 6 to 7 in 2 d. They were harvested by centrifugation of the cultures at 3,000 rpm for 5 min, and then the supernatants were analyzed by ELISA. At the same time, the OD600 of a suitablydiluted culture was measured. Routinely, for each strain for which interferon-secretion was assessed, 5 transformants were analyzed in parallel.
Results and Discussion
Isolation of S. cerevisiae TIY20-1 (M5) and YAB101-1 (M5 Mut) producing Man 5 GlcNAc 2 oligosaccharide Man 8 GlcNAc 2 N-linked oligosaccharides must be converted by -1,2-mannosidase to obtain glycoproteins with a Man 5 GlcNAc 2 structure, an intermediate of human hybrid and complex type oligosaccharides. A previous our attempt to introduce -1,2-mannosidase activity into yeast demonstrated its feasibility, but the engineered strain had growth defects that resulted in low yields of heterologously produced protein. In this strain, -1,2-mannosidase was expressed from a plasmid and tagged with the His-Asp-Glu-Lue (HDEL) peptide, 8) which acts as a retention/retrieval signal for the endoplasmic reticulum (ER) in yeast cells, 20) but of the Man 8 GlcNAc 2 N-linked oligosaccharides, not more than 10% was converted to Man 5 GlcNAc 2 . 8) To enhance the formation of Man 5 GlcNAc 2 , -1,2-mannosidase (msdS) was fused to the transmembrane domain (TMD) of S. cerevisiae Och1, an integral type-II membrane protein that is part of the Golgi apparatus. 21, 22) The expression cassette, containing OCH1-TMD-msdS under the control of the GAPDH promoter (Fig. 1A) , was integrated at the TRP1 locus into 2 strains with a W303 background, YAB101 (M8 Mut) and TIY20 (M8), that form Man 8 GlcNAc 2 glycoproteins after disruption of yeast-specific glycosyl transferase genes OCH1, MNN1, and MNN4. YAB101 (M8 Mut) has been derived from TIY20 (M8) to overcome the growth defect and the temperature-sensitive phenotype of the TIY20 strain (M8).
10) The resulting strains, in which the expression of the OCH1TMD-msdS fusion was confirmed by RT-PCR (data not shown), were designated YAB101-1 (M5 Mut) and TIY20-1 (M5) respectively (Table 1) .
Growth analysis of these strains at 30 C in liquid medium (Fig. 1B) and by serial dilution on solid media (Fig. 1C) showed a higher growth rate for YAB101-1 (M5 Mut) than for TIY20-1 (M5), while the growth of YAB101-1 (M5 Mut) did not differ from that of parental YAB101 (M8 Mut), indicating that the expression of OCH1TMD-msdS did not have an impact on the growth of this strain. That the presence of OCH1TMD-msdS did not affect growth was underlined by the finding that temperature sensitivity of TIY20-like cells (M8) remained unchanged, whereas the YAB101-1 cells (M5 Mut) grew as well as their parental strain at 37 C (Fig. 1C) .
Analysis of the structures of the N-linked oligosaccharides
In order to determine the effect of expression of the -1,2-mannosidase fused to the transmembrane domain of Och1, we compared the structure of N-linked oligosaccharides in the cell-wall mannoprotein from strains YAB101 (M8 Mut), TIY20 (M8), YAB101-1 (M5 Mut), and TIY20-1 (M5) by HPLC after digestion with glycopeptidase F and pyridylamination (see ''Materials and Methods'' above) (Fig. 2) . Confirming previous analysis, 10) the oligosaccharide structure from TIY20 (M8) and YAB101 (M8 Mut) was Man 8 GlcNAc 2 , while the expression of -1,2-mannosidase in either TIY20-1 (M5) or YAB101-1 (M5 Mut) resulted in a mixture of Man 5-8 GlcNAc 2 , and more than 60% of the oligosaccharides of the cell-wall mannoprotein were converted to Man 5 GlcNAc 2 . This ratio is much higher than the 10% that has been reported previously for a strain in which -1,2-mannosidase was tagged with the HDEL peptide and expressed from a plasmid. 8) Proteins with the HDEL peptide enter a retrograde transport pathway for return to the ER from the Golgi apparatus. 23, 24) Choi et al. achieved high efficiency in the conversion to Man 5 GlcNAc 2 by using a transmembrane domain of the type-II membrane protein of yeast to localize -1,2-mannosidase to the secretory pathway of P. pastoris.
5) Thus, the cellular localization of -1,2-mannosidase using a type-II transmembrane domain appears to contribute to the efficiency with which Man 8 GlcNAc 2 is converted to Man 5 GlcNAc 2 . This conversion might even be enhanced by increasing the expression level of -1,2-mannosidase. Thus the more efficient conversion to Man 5 GlcNAc 2 in our system have been the result of anchoring -1,2-mannosidase with a type-II transmembrane domain, while genomic integration of the OCHTMD-msdS cassette might lead to more efficient expression of the gene.
Production of human interferon-
To determine whether the engineered strains are suitable for producing heterologous glycoproteins, we analyzed the efficiency of secretion of human interferon-(hIFN-) from TIY20-1 (M5) and YAB101-1 (M5 Mut). hIFN-is a glycoprotein secreted by fibroblasts in response to viral infection or exposure to doublestranded RNA. 25) It functions as an anti-viral and antitumor agent. The gene for hIFN-was fused to the prepro-sequence of the -factor gene to facilitate secretion, and was expressed by the GAPDH promoter on plasmid YEp352GAPII-MFhIFN- (Fig. 3A) , which was transformed into TIY20-1 (M5) and YAB101-1 (M5 Mut). Five transformants from each strain were cultured in YPAD for 3 d, and then the levels of secreted hIFNwere measured by ELISA. As shown in Fig. 3B , compared to the TIY20-1 strain (M5), the YAB101-1 strain (M5 Mut) secreted about 14-fold more hIFNinto the growth media. This result suggests that the increased fitness obtained by the mutagenesis procedure based on the disparity theory of evolution also had a positive effect on hIFN-productivity. A, Schematic overview of the OCH1TMD-msdS expression cassette with the GAPDH-promoter and terminator. B, Growth analysis of YAB101-1 (solid circles) and TIY20-1 (hollow circles) in liquid culture. At the indicated time points, OD600 measurements were made to monitor cell growth. C, Growth analysis by serial dilution on plates.
A vacuolar protease-deficient version of YAB101-1 (M5 Mut)
A factor that limits the yield of heterologously produced proteins is degradation by host-specific proteases released into the medium due to fermentation stress or cell-lysis. 14, 26) In order to determine whether the levels of secreted hIFN-can be enhanced by disruption of vacuolar proteases, the genes for PEP4 and PRB1 were disrupted in YAB101-1 (M5 Mut). PEP4 and PRB1 are essential for the maturation and activation of other vacuolar proteases in that their disruption effectively creates a protease-deficient strain.
14) The PEP4 gene was disrupted in YAB101-1 (M5 Mut), yielding YAB101-2 (M5 Mut pep4Á) (Table 1) , while disruption of PRB1 in YAB101-1 (M5 Mut) and YAB101-2 (M5 Mut pep4Á) resulted in YAB101-3 (M5 Mut prb1Á) and YAB101-4 (M5 Mut pep4Á prb1Á) respectively. Analyzed at 30 C, the growth rates of these strains showed no differences, indicating that the deletion of vacuolar proteases in our glycoengineered strains did not affect cell growth (Fig. 4A) .
The secretion of hIFN-by YAB101-1 (M5 Mut), YAB101-2 (M5 Mut pep4Á), YAB101-3 (M5 Mut prb1Á), and YAB101-4 (M5 Mut pep4Á prb1Á) was assessed after transformation with hIFN-expression plasmid YEp352GAPII-MFhIFN-(see ''Material and Methods'' above). Cells were grown for 2 d and then the amount of hIFN-in the culture medium was measured by ELISA (Fig. 4B) . Secretion of hIFN-by YAB101-4 (M5 Mut pep4Á prb1Á) increased approximately 10-fold as compared to YAB101-1 (M5 Mut), suggesting that decreased protease activity in the double deletion mutant provides the optimal genetic background to produce secreted hIFN-.
Still, the secretion levels were too poor to obtain sufficient amounts of hIFN-to analyze its oligosaccharide structures. Demolder et al. have reported that induction of hIFN-in their strain, which was also deficient in vacuolar proteinases, was toxic and inhibited cell proliferation. 27) This phenomenon, however, was not observed in our strains (data not shown), perhaps due to the inclusion of sorbitol in the growth medium (see ''Materials and Methods'' above). Demolder et al.
also found that they could increase the secretion level of hIFN-by overexpression of HSP70.
27) Thus, it is possible that overexpression of this chaperone in our strains also helps to raise the secretion of hIFN-. Despite the big difference in strain background that Demolder et al. used an integrated hIFN-expressioncassette under the control of the inducible GAL1 promoter, 27) our set-up with an episomal plasmid and the constitutive GAPDH-promoter in a glycoengineered strain gave similarly poor secretion of hIFN-suggesting that other, less well-known, variables affect the heterologous production of this glycoprotein. Still, the present study indicates that disruption of PEP4 and PRB1 improved hIFN-secretion efficiency in a yeast strain that synthesized glycoprotein with Man 5 GlcNAc 2 oligosaccharide. Hence we believe that YAB101-4 (M5 Mut pep4Á prb1Á) is favorable to use as a starting strain for more complex glycoengineering to make possible the production of proteins with mammalian Nlinked oligosaccharides. To our knowledge, YAB101-4 (M5 Mut pep4Á prb1Á), which was isolated in this study, is the most useful strain for the synthesis of glycoproteins with Man 5 GlcNAc 2 oligosaccharide in S. cerevisiae. 
